Delivery Order SPE2DB20D1047-SPE2DB25FF72S
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,846.27 by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3mL) with a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 4, 2025, and performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under a larger contract vehicle, representing...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract, valued at $7,888.63, is structured as a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. Performance will be completed at the vendor's Conshohocken facility by the ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a $5,358.33 delivery order from the Defense Logistics Agency on June 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml vials. The contract utilizes firm fixed price pricing and is classified as a non-set-aside award, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a $10,386.66 firm fixed price delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order is scheduled for completion by July 31, 2025, with performance to be executed at...
- AmerisourceBergen Drug Corp received a $7,039.64 delivery order from the Defense Logistics Agency (DLA) on April 23, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 ml), with completion scheduled for April 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical products will be delivered to the company's corporate office location...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $2,870.86 and is scheduled for completion by July 31, 2025. The award represents a child contract action under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp has been awarded a $5,478.84 delivery order by the Defense Logistics Agency for Ozempic 0.25-0.5 mg/dose pens (3 mL), with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is...
- AmerisourceBergen Drug Corp received a delivery order valued at $27,049.15 from the Defense Logistics Agency (DLA) on August 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml). This firm fixed-price contract, which carries an ultimate completion date of August 13, 2025, was awarded without a set-aside designation through competitive procurement. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Ozempic (0.25-0.5 mg/dose pen, 3ml) with a ceiling value of $31,714.28. The contract employs firm fixed pricing with an ultimate completion date of July 30, 2025. This award is classified as a competitive delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $37,417.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3 mL formulations, with completion targeted for September 15, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader relationship...